GSE17112 which included endogenous GINS1-high-expression and GINS1-low-expression cells and GSE143233 which included 3 normal HCC patients and 3 sorafenib-resistant HCC patients were analyzed. This evidence concerns the gene GINS1 and hepatocellular carcinoma.